VOYA INVESTMENT MANAGEMENT LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$401,000
+99.5%
66,434
+19.0%
0.00%
Q3 2019$201,000
+34.0%
55,8190.0%0.00%
Q2 2019$150,000
-9.1%
55,8190.0%0.00%
Q1 2019$165,000
+85.4%
55,8190.0%0.00%
Q4 2018$89,000
-56.6%
55,8190.0%0.00%
Q3 2018$205,000
+29.7%
55,8190.0%0.00%
Q2 2018$158,000
-23.7%
55,8190.0%0.00%
Q1 2018$207,000
+28.6%
55,8190.0%0.00%
Q4 2017$161,000
-35.9%
55,8190.0%0.00%
-100.0%
Q3 2017$251,000
-2.0%
55,8190.0%0.00%0.0%
Q2 2017$256,000
+23.7%
55,819
+13.7%
0.00%
Q1 2017$207,000
+2.0%
49,0890.0%0.00%
Q4 2016$203,000
-49.0%
49,0890.0%0.00%
-100.0%
Q3 2016$398,000
+3.9%
49,0890.0%0.00%0.0%
Q2 2016$383,000
+1.1%
49,0890.0%0.00%0.0%
Q1 2016$379,000
-28.5%
49,0890.0%0.00%0.0%
Q4 2015$530,000
+56.3%
49,0890.0%0.00%0.0%
Q3 2015$339,000
-31.7%
49,089
-12.3%
0.00%0.0%
Q2 2015$496,000
-10.1%
56,0010.0%0.00%0.0%
Q1 2015$552,000
-19.5%
56,0010.0%0.00%
-50.0%
Q4 2014$686,000
+13.0%
56,001
-8.0%
0.00%
+100.0%
Q3 2014$607,000
+21.4%
60,843
-8.0%
0.00%0.0%
Q2 2014$500,000
+70.6%
66,105
-25.7%
0.00%0.0%
Q1 2014$293,000
-0.7%
88,9440.0%0.00%0.0%
Q4 2013$295,000
+60.3%
88,944
+45.8%
0.00%
Q3 2013$184,000
-63.1%
61,0080.0%0.00%
-100.0%
Q2 2013$499,00061,0080.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
RA Capital Management 11,733,815$81,081,00011.64%
RTW INVESTMENTS, LP 2,589,818$17,896,0005.56%
DAFNA Capital Management LLC 480,300$3,319,0003.29%
DOHENY ASSET MANAGEMENT /CA 510,125$3,525,0001.83%
Sio Capital Management, LLC 364,368$2,518,0001.73%
TURNER INVESTMENTS LLC 1,086,000$7,504,0001.52%
Ghost Tree Capital, LLC 300,000$2,073,0000.93%
Rock Springs Capital Management LP 1,125,000$7,774,0000.63%
SENZAR ASSET MANAGEMENT, LLC 619,000$4,277,290,0000.62%
Point72 Asset Management, L.P. 9,772,018$67,525,0000.53%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders